NYSE - Delayed Quote USD

Fortive Corporation (FTV)

Compare
74.40 +0.69 (+0.94%)
At close: August 30 at 4:00 PM EDT
74.19 -0.21 (-0.28%)
After hours: August 30 at 6:04 PM EDT
Loading Chart for FTV
DELL
  • Previous Close 73.71
  • Open 73.97
  • Bid 70.89 x 800
  • Ask 74.41 x 900
  • Day's Range 73.67 - 74.58
  • 52 Week Range 63.05 - 87.10
  • Volume 2,974,237
  • Avg. Volume 1,926,834
  • Market Cap (intraday) 26.065B
  • Beta (5Y Monthly) 1.16
  • PE Ratio (TTM) 29.88
  • EPS (TTM) 2.49
  • Earnings Date Oct 23, 2024 - Oct 28, 2024
  • Forward Dividend & Yield 0.32 (0.43%)
  • Ex-Dividend Date May 31, 2024
  • 1y Target Est 83.39

Fortive Corporation designs, develops, manufactures, and services professional and engineered products, software, and services in the United States, China, and internationally. It operates in three segments: Intelligent Operating Solutions, Precision Technologies, and Advanced Healthcare Solutions. The Intelligent Operating Solutions segment provides advanced instrumentation, software, and services, including electrical test and measurement, facility and asset lifecycle software applications, and connected worker safety and compliance solutions for manufacturing, process industries, healthcare, utilities and power, communications and electronics, and other industries. This segment markets its products and services under the ACCRUENT, FLUKE, GORDIAN, INDUSTRIAL SCIENTIFIC, INTELEX, PRUFTECHNIK, and SERVICECHANNEL brands. The Precision Technologies segment offers electrical test and measurement, sensing and material technologies for industrial, power and energy, automotive, medical equipment, food and beverage, aerospace and defense, semiconductor, and other general industries under the ANDERSON-NEGELE, GEMS, SETRA, HENGSTLER-DYNAPAR, QUALITROL, PACIFIC SCIENTIFIC, KEITHLEY, and TEKTRONIX brand names. The Advanced Healthcare Solutions segment provides critical workflow solutions comprising instrument sterilization, instrument tracking, design and manufacture of cell therapy equipment, biomedical test tools, radiation detection and safety monitoring, and end-to-end clinical productivity software and solutions under the ASP, CENSIS, CENSITRAC, EVOTECH, FLUKE BIOMEDICAL, INVETECH, LANDAUER, PROVATION, RAYSAFE, and STERRAD brands. Fortive Corporation was incorporated in 2015 and is headquartered in Everett, Washington.

www.fortive.com

18,000

Full Time Employees

December 31

Fiscal Year Ends

Recent News: FTV

View More

Performance Overview: FTV

Trailing total returns as of 8/30/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

FTV
1.25%
S&P 500
18.42%

1-Year Return

FTV
4.94%
S&P 500
25.59%

3-Year Return

FTV
1.72%
S&P 500
25.26%

5-Year Return

FTV
28.26%
S&P 500
93.14%

Compare To: FTV

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: FTV

View More

Valuation Measures

Annual
As of 8/30/2024
  • Market Cap

    26.07B

  • Enterprise Value

    29.20B

  • Trailing P/E

    29.88

  • Forward P/E

    19.57

  • PEG Ratio (5yr expected)

    1.34

  • Price/Sales (ttm)

    4.29

  • Price/Book (mrq)

    2.48

  • Enterprise Value/Revenue

    4.74

  • Enterprise Value/EBITDA

    17.78

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    14.39%

  • Return on Assets (ttm)

    4.42%

  • Return on Equity (ttm)

    8.65%

  • Revenue (ttm)

    6.16B

  • Net Income Avi to Common (ttm)

    885.7M

  • Diluted EPS (ttm)

    2.49

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    644.1M

  • Total Debt/Equity (mrq)

    37.56%

  • Levered Free Cash Flow (ttm)

    1.1B

Research Analysis: FTV

View More

Company Insights: FTV

Research Reports: FTV

View More

People Also Watch